Viewing Study NCT04831450

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT04831450
Status: WITHDRAWN
Last Update Posted: 2022-08-04
First Post: 2021-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor: University of Miami
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None HNSCC View
None Squamous Cell Carcinoma of the Larynx View
None Squamous Cell Carcinoma of the Oral Cavity View
None Squamous Cell Carcinoma of Hypopharynx View
Keywords: